We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
AAOI | Applied Optoelectronics Inc | 11.26 | 0.00 | 0.00% | 0 |
AAON | AAON Inc | 88.56 | 0.00 | 0.00% | 0 |
AAPB | GraniteShares ETF Trust GraniteShares | 16.45 | 0.00 | 0.00% | 0 |
AAPD | Direxion Daily AAPL ETF | 23.31 | 0.00 | 0.00% | 0 |
AAME | Atlantic American Corporation | 1.92 | 0.00 | 0.00% | 0 |
AAL | American Airlines Group Inc | 14.23 | 0.00 | 0.00% | 0 |
AACI | Armada Acquisition Corporation I | 11.27 | 0.00 | 0.00% | 0 |
AADI | Aadi Bioscience Inc | 1.84 | 0.00 | 0.00% | 0 |
AADR | AdvisorShares Dorsey Wright ADR ETF | 61.09 | 0.00 | 0.00% | 0 |
AAGR | African Agriculture Holdings Inc | 0.35 | 0.00 | 0.00% | 0 |
AACG | ATA Creativity Global | 0.8906 | 0.00 | 0.00% | 0 |
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has accepted its New Drug Submission (NDS) for trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Health Canada has granted Priority Review for Acadia’s submission.
Pilot plant produces qualification samples for strategic customers and demonstrates commercial maturity of internally-developed production process RENO, Nev., April 22, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, announced the completion of construction and start of commissioning of its lithium hydroxide (LiOH) pilot plant marking a significant milestone in the commercialization of its internally-developed processes to access an unrealized domestic primary lithium resource.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,639.36 | 228.80 | 0.34% | 1.31T | 3,033,238,126 |
ETH | Ethereum | 3,252.21 | 31.74 | 0.99% | 391.09B | 1,770,052,603 |
USDT | Tether USD | 0.9999 | -0.00009 | -0.01% | 97.84B | 388,012,617 |
BNB | Binance Coin | 608.67 | 2.48 | 0.41% | 95.84B | 477,864,836 |
SOL | Solana | 158.01 | 3.40 | 2.20% | 69.66B | 1,164,535,290 |
STETH | stETH | 3,237.05 | 18.83 | 0.59% | 31.91B | 2,126,481 |
XRP | Ripple | 0.5494 | 0.0047 | 0.86% | 30B | 382,852,067 |
USDC | USD Coin | 0.9998 | -0.0001 | -0.01% | 28.07B | 1,122,813,576 |
DOGE | Dogecoin | 0.16139 | 0.00153 | 0.96% | 23.13B | 405,787,829 |
TONCOIN | Wrapped TON Coin | 5.86 | 0.166338 | 2.92% | 20.83B | 145,441,654 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions